By Matt Fair (September 24, 2021, 12:44 PM EDT) -- The first case in Philadelphia over alleged health risks associated with Johnson & Johnson's signature talcum powder came to an end Friday as a state jury cleared the company of claims that its product contributed to a woman's ovarian cancer diagnosis.
A Philadelphia jury cleared Johnson & Johnson on Friday of claims its talcum powder contributed to a woman's case of ovarian cancer. (Photo by AaronP/Bauer-Griffin/GC Images) The jurors rejected arguments from Ellen Kleiner and her husband that J&J's talcum powder had been a contributing factor in a case of ovarian cancer she was diagnosed with in June 2011 after using...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!